Prophylactic treatment of chemotherapy-induced neutropenia with Lipegfilgrastim in patients with NHL: Subgroup analysis of the non-interventional study NADIR

被引：0
|
作者：
Fietz, T. [1 ]
Wolff, T. [2 ]
Sandner, R. [3 ]
Janssen, J. [4 ]
Hurtz, H. -J. [5 ]
Heits, F. [6 ]
Weide, R. [7 ]
Weissenborn, G. [8 ]
Losem, C. [9 ]
Lueck, A. [10 ]
Kurbacher, C. M. [11 ]
Teichmann, B. [12 ]
Harde, J. [12 ]
Scheuerlein, R. W. [13 ]
机构：
[1] Schwerpunktpraxis Innere Med Hamatol Onkol & Gast, Singen, Germany
[2] OncoRes Lerchenfeld GmbH, Hamburg, Germany
[3] Gemeinschaftspraxis Hamatol & Internist Onkol, Passau, Germany
[4] Gemeinschaftspraxis Hamatol & Onkol, Westerstede, Germany
[5] Onkol Gemeinschaftspraxis, Halle, Saale, Germany
[6] Agaples Diakonieklinikum Rotenburg gGmbH, Rotenburg, Wumme, Germany
[7] Praxis Hamatol & Onkol, Koblenz, Germany
[8] Praxis Hamatol & Onkol, Twistringen, Germany
[9] Praxis Onkol & Hamatol, Neuss, Germany
[10] Zentrum Urol & Onkol, Rostock, Germany
[11] Med Zentrum Bonn Friedenspl Schwerpunkt Gynakol O, Bonn, Germany
[12] IOMEDICO AG, Freiburg, Germany
[13] TEVA GmbH, Berlin, Germany
来源：
Oncology Research and Treatment | 2015年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P256
引用
收藏
页码：78 / 78
页数：1
相关论文
共 50 条
  • [41] Management of chemotherapy-induced symptomatic anemia with epoetin theta as documented in the multicentre, non-interventional study EPO-amb
    Link, H.
    Lueck, A.
    Rauh, J.
    Borquez, D.
    Maas, C.
    Hesse, J.
    Koenigsmann, M.
    Schulze, M.
    Toelg, M.
    Scheuerlein, R. W.
    [J]. Oncology Research and Treatment, 2015, 38 : 76 - 76
  • [42] Experience with prophylactic oral ciprofloxacin in gynecological cancer patients developing severe chemotherapy-induced neutropenia
    Maurie Markman
    Alexander Kennedy
    Kenneth Webster
    Gertrude Peterson
    Barbara Kulp
    Jerome Belinson
    [J]. Journal of Cancer Research and Clinical Oncology, 2000, 126 : 298 - 300
  • [43] Experience with prophylactic oral ciprofloxacin in gynecological cancer patients developing severe chemotherapy-induced neutropenia
    Markman, M
    Kennedy, A
    Webster, K
    Peterson, G
    Kulp, B
    Belinson, J
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2000, 126 (05) : 298 - 300
  • [44] BUDGET IMPACT ANALYSIS OF SARGRAMOSTIM USE IN PATIENTS WITH CHEMOTHERAPY-INDUCED NEUTROPENIA
    Toy, E. L.
    Porter, C. L.
    Books, P.
    Vekeman, F.
    Barghout, V
    Duh, M.
    Skarin, A. T.
    [J]. VALUE IN HEALTH, 2009, 12 (03) : A39 - A39
  • [45] Budget impact analysis of sargramostim use in patients with chemotherapy-induced neutropenia
    Duh, M.
    Toy, E. L.
    Porter, C. L.
    Books, P. L.
    Vekeman, F.
    Barghout, V.
    Skarin, A. T.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [46] Efficacy, safety and feasibility of fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting in pediatric patients receiving moderately and highly emetogenic chemotherapy – results of a non-interventional observation study
    Semjon Willier
    Karin Melanie Cabanillas Stanchi
    Martina von Have
    Vera Binder
    Franziska Blaeschke
    Judith Feucht
    Tobias Feuchtinger
    Michaela Döring
    [J]. BMC Cancer, 19
  • [47] Efficacy, safety and feasibility of fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting in pediatric patients receiving moderately and highly emetogenic chemotherapy - results of a non-interventional observation study
    Willier, Semjon
    Cabanillas Stanchi, Karin Melanie
    von Have, Martina
    Binder, Vera
    Blaeschke, Franziska
    Feucht, Judith
    Feuchtinger, Tobias
    Doering, Michaela
    [J]. BMC CANCER, 2019, 19 (01)
  • [48] Biosimilar filgrastim in the treatment and prevention of chemotherapy-induced neutropenia in patients with breast cancer: A sub-analysis of the NEXT study
    Kamioner, D.
    Lepretre, S.
    Maloisel, F.
    Berthou, C.
    Albrand, H.
    [J]. EUROPEAN JOURNAL OF CANCER, 2015, 51 : S242 - S243
  • [49] Biosimilar filgrastim in the treatment and prevention of chemotherapy-induced neutropenia in patients with solid tumours: a sub-analysis of the NEXT study
    Maloisel, F.
    Lepretre, S.
    Kamioner, D.
    Berthou, C.
    Albrand, H.
    [J]. BONE MARROW TRANSPLANTATION, 2015, 50 : S307 - S308
  • [50] Subgroup Analysis of the Non-interventional REASON Study: PFS and OS According to Age, Smoking History, Gender, and Histology in NSCLC Patients Treated with Gefitinib or Chemotherapy
    Schuette, W.
    Eberhardt, W. E. E.
    Waller, C.
    Schirmacher, P.
    Dietel, M.
    Zirrgiebel, U.
    Radke, S.
    Thomas, M.
    [J]. PNEUMOLOGIE, 2016, 70 (09): : 579 - 588
12345